CVS Paying $36.5 Million for Overbilling Medi-Cal for Insulin Pens

CVS is paying $36.5 million for submitting false claims to the Medi-Cal program for excessive dispensing of insulin pens. A settlement pursued by California Attorney General Rob Bonta in collaboration with the United States Department of Justice with CVS Pharmacy, …

Commercial risk teams are responding with tighter controls, scenario modeling, and broader collaboration across underwriting, claims, and cyber operations.

Leaders continue to prioritize resilience planning while balancing cost, coverage terms, and operational exposure in a changing market cycle.